share_log

Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session

Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session

為什麼 MediChurin 的交易價格下降了 18% 左右,這裡有 48 隻股票在周四的中午時段移動
Benzinga Real-time News ·  2022/09/22 12:28
Gainers
贏家
Spero Therapeutics, Inc. (NASDAQ:SPRO) rose 150% to $2.0508 after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront, with potential for future milestone payments, and tiered royalties. HeartBeam, Inc. (NASDAQ:BEAT) shares gained 34% to $2.12 after dropping 16% on Wednesday. Heartbeam recently announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO. ShiftPixy, Inc. (NASDAQ:PIXY) shares jumped 32.4% to $18.09. ShiftPixy, on Wednesday, announced pricing of $5 million private placement. Inventiva...
Spero治療公司納斯達克(SPRO)股價上漲150%,至2.0508美元,此前該公司宣佈與葛蘭素史克簽訂了斯培羅晚期抗生素資產替比培南HBR的獨家許可協議。Spero Treateutics將獲得...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論